MiR-10a as a Potential Biomarker and Therapeutic Target in Localized and Metastatic Prostate Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Prostate cancer (PC) is a major global health concern, with localized disease curable but a significant progression rate to metastatic forms.
• MicroRNAs (miRNAs) are crucial molecular markers for cancer diagnosis and treatment, yet the specific role of miR-10a in PC remains debated.
• Understanding miR-10a's function is vital for developing novel therapeutic strategies against metastatic PC.

Purpose of the Study:

• To investigate the role of miR-10a in metastatic prostate cancer (PC) cell lines.
• To analyze the impact of miR-10a on PC cell proliferation, migration, and invasion mechanisms.
• To assess miR-10a expression levels in surgical specimens of localized PC.

Main Methods:

• Utilized three commercial metastatic PC cell lines (LNCaP, DU145, PC-3) for transfection with miR-10a mimics.
• Quantified miR-10a and target gene (VEGF, MYC, HAS3) expression using real-time PCR after miRNA and RNA extraction.
• Assessed cellular functions including invasion, migration, and proliferation using Matrigel assays and colony formation tests; analyzed miR-10a in surgical specimens.

Main Results:

• Transfection significantly upregulated miR-10a expression across all tested PC cell lines (LNCaP, PC-3, DU145).
• Elevated miR-10a levels markedly reduced cell invasion in PC-3 and DU145 cells, and also decreased cell migration and proliferation.
• Surgical specimens revealed significantly higher miR-10a expression in PC tissues compared to Benign Prostatic Hyperplasia (BPH).

Conclusions:

• Increased miR-10a expression demonstrates an inhibitory effect on prostate cancer cell migration, invasion, and proliferation.
• miR-10a emerges as a promising molecular marker for PC and a potential therapeutic target for managing the disease.
• Further research into miR-10a's regulatory pathways could unlock new avenues for PC treatment.